New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 25, 2013
10:02 EDTSFLY, RRD, VIPS, LXP, DRRX, EROC, GALE, CMCSA, CEB, BRS, CNDOOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Bristow Group (BRS) initiated with an Overweight at JPMorgan... Comcast (CMCSA) reinstated with a Buy at Goldman... Coronado Biosciences (CNDO) initiated with a Buy at Canaccord... Corporate Executive Board (CEB) initiated with a Buy at SunTrust... Eagle Rock Energy (EROC) coverage resumed with a Market Perform at Wells Fargo... Galena Biopharma (GALE) initiated with a Buy at Needham... Lexington Realty (LXP) initiated with a Hold at KeyBanc... Rentech Nitrogen (RNF) initiated with a Neutral at Goldman... R.R. Donnelley (RRD) initiated with a Buy at Sidoti... Durect (DRRX) initiated with a Buy at Stifel... Vipshop (VIPS) initiated with an Overweight at JPMorgan... Shutterfly (SFLY) initiated with a Buy at Needham... Coronado Biosciences (CNDO) initiated with a Buy at Canaccord.
News For BRS;CMCSA;CNDO;CEB;GALE;EROC;LXP;RRD;DRRX;VIPS;SFLY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
November 19, 2014
13:06 EDTCMCSADeutsche Telekom CEO says T-Mobile could again attract suitors, Bloomberg says
Bloomberg quotes Deutsche Telekom (DTEGY) CEO Timotheus Hoettges speaking in interview as having said that T-Mobile (TMUS) could attract interest from suitors such as Comcast (CMCSA), DISH (DISH) or America Movil (AMOV, AMX).
10:21 EDTVIPSVipshop drops on outlook, levels to watch
The company reported a beat on Q3 yesterday after the close, but offered guidance that disappointed traders. At the current price of $21.25 the stock is down over 10.2%. Support is at $20.59, the low of the day, and then at $20. Resistance is at $21.92, the session high.
09:16 EDTVIPSOn The Fly: Pre-market Movers
Subscribe for More Information
07:44 EDTEROCRBC Capital to hold a conference
Subscribe for More Information
November 18, 2014
18:23 EDTVIPSOn The Fly: After Hours Movers
UP AFTER EARNINGS: La-Z-Boy (LZB), up 4.7% after reporting second quarter results and dividend increase... Jack in the Box (JACK), up 2.7%... PetSmart (PETM), up 1.9%. ALSO HIGHER: Popeyes Louisiana Kitchen (PLKI), up 1.6% after Red Mountain Capital Partners reported a 5.1% stake in the company. DOWN AFTER EARNINGS: Vipshop Holdings (VIPS), down 4.6%. ALSO LOWER: Cloud Peak (CLD), down 1.7% after filing to sell $100M of mandatory convertible preferred stock.
16:42 EDTVIPSVipshop down almost 3.5% to $22.90 after reporting Q3 results, guidance
Subscribe for More Information
16:03 EDTVIPSVipshop sees Q4 revenue $1.2B-$1.22B, consensus $1.21B
Subscribe for More Information
16:02 EDTVIPSVipshop reports Q3 EPS 8c, consensus 7c
Reports Q3 revenue $882.6M, consensus $863.12M.
15:46 EDTVIPSVipshop November 22 straddle priced for 9.6% move into Q3
Subscribe for More Information
15:21 EDTVIPSNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Vipshop Holdings (VIPS), consensus 7c; M/A-Com Technology (MTSI), consensus 33c; La-Z-Boy (LZB), consensus 34c; PetSmart (PETM), consensus 94c; Jack in the Box (JACK), consensus 53c.
14:01 EDTVIPSVipshop November volatility elevated into Q3 and outlook
Subscribe for More Information
07:37 EDTGALEStifel to hold a conference
Subscribe for More Information
07:09 EDTGALEGalena completes enrollment in GALE-401 Phase 2 clinical trial
Galena Biopharma announced the completion of enrollment in the GALE-401, or Anagrelide Controlled Release, Phase 2 Clinical Trial. The Phase 2, clinical proof-of-concept study is treating 18 patients with elevated platelet counts in myeloproliferative neoplasms, or MPNs, including Essential Thrombocythemia, or ET, Polycythemia Vera, or PV, and Primary Myelofibrosis, or PMF. The Phase 2 trial is an open-label, single-arm, multicenter study designed to confirm the platelet-lowering activity of GALE-401 in patients with MPNs, to assess safety and tolerability, and to measure plasma concentrations of anagrelide. The platelet lowering ability of GALE-401 will be measured by the proportion of patients that achieve a complete or partial platelet response for at least four weeks during 24 weeks of treatment. With enrollment complete, patients will now be followed for platelet response while they continue study treatment.
November 17, 2014
17:31 EDTCNDODaryl Katz reports 6.45% passive stake in Coronado
Subscribe for More Information
09:03 EDTSFLYShutterfly acquires GrooveBook for $14.5M
Shutterfly has acquired GrooveBook, a mobile photo book app subscription service that sends customers a keepsake book of their mobile phone photos each month, for $14.5M, which includes an upfront purchase amount and a future performance-based earn-out.
06:35 EDTCMCSA'Dumb and Dumber To' takes first at the box office from 'Big Hero 6', WSJ says
Comcast (CMCSA) company Universal Pictures' "Dumb and Dumber To" brings in $38.1M at the box office, taking first away from Disney's (DIS) "Big Hero 6," which brought in $36M this weekend, reports the Wall Street Journal. "Big Hero 6" has a two week total of $111.7M in North America, the Journal adds. Reference Link
November 14, 2014
15:04 EDTVIPSVipshop November volatility elevated into Q3 and outlook
Subscribe for More Information
November 13, 2014
09:06 EDTCMCSAComcast and Boys & Girls Clubs of America launch My Future Technology initiative
Comcast NBCUniversal and Boys & Girls Clubs of America have entered into a five-year national partnership valued at tens of millions of dollars in cash and in-kind support. The partnership includes the launch of My.Future, a new technology initiative designed to teach Club members about our digital world and ignite their passion for technology.
06:17 EDTCMCSASony unveils PlayStation Vue, a cloud-based TV service
Subscribe for More Information
06:02 EDTCMCSAComcast moving ahead with $45B acquisition of Time Warner Cable, AP reports
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use